coexistence with other liver diseases such as alcoholic liver disease, autoimmune hepatitis, drug-induced liver injury, or other viral infections(hepatitis A, C, and E virus or HIV infection).
concomitant with malignant tumor or other serious diseases affecting survival time.
patients with missing data. follow-up period of \<48 weeks.